• 19057

Nayera Elshakankery, MD

    Molecular Biology Consultant and Head of HLA Typing Unit

Molecular Biology Consultant and Head of HLA Typing Unit


Professor of Clinical Pathology, National Cancer Institute, Cairo University.

Education:

  • MD. Clinical Pathology, Faculty of Medicine ,Cairo University.
  • MSc. Clinical Pathology, Faculty of Medicine ,Cairo University.
  • BSc. Medicine and Surgery, Faculty of Medicine, Cairo University.

Selected Publications:

  • Clinical significance of immunophenotypic markers in pediatric T- cell Acute lymphoblastic leukemia. Nayera Hamdy, The Journal of the Egyptian National Cancer Institute. 20 (2), 111-120, 2008.
  • Bcl2 protein expression in Egyptian acute myeloid leukemia. Nayera Hamdy, The Journal of the Egyptian National Cancer Institute. 21 (1), 71-76, 2009.
  • High dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next? Nayera Hamdy, J Cancer Res.Clin Oncol. 140 (8) 1359-65, 2014.
  • Vitamin D receptor polymorphism in Egyptian pediatric acute lymphoblastic leukemia correlation with BMD. Nayera Hamdy,Meta Gene. (9) 42-46, 2016.
  • Detection of kit mutation in core binding factor acute myeloid leukemia. Nayera Hamdy,Leukemia research reports (10) 20-25, 2018.
  • HLA Haplotypes In 250 Families: The Baylor Laboratory Results And A Perspective On A Core NGS Testing Model For The 17th International HLA And Immunogenetics Workshop. Nayera Hamdy, Human Immunology, 80, (11), 897-905, 2019.
  • Low expression of miR-204 is associated with expression of CD34 and poor performance status in denovo AML. Nayera Hamdy, Int J Lab Hematol. 2020.
  • Outcome of Core Binding Factor Acute Myeloid Leukemia by Receptor Tyrosine Kinase Mutation. Nayera Hamdy, Clinical Lymphoma, Myeloma & Leukemia,20 (7), 459- 467, 2020.
  • Outcome of Childhood Acute Myeloid Leukemia With FLT3-ITD Mutation: The Experience of Children’s Cancer Hospital Egypt, 2007-17. Nayera Hamdy,Clinical Lymphoma, Myeloma & Leukemia 529-539, 2020.
  • Outcomes of allogenic hematopoietic cell transplantation for childhood chronic myeloid leukemia: Single-center experience. Nayera Hamdy, Pediatric Transplantation. 2020.
  • RAS Pathway Mutation Patterns in Patients With Juvenile Myelomonocytic Leukemia: A Developing Country Single-center Experience. Nayera Hamdy, Clinical Lymphoma, Myeloma & Leukemia 368-374, 2020.
  • Characterization of CRLF2 Expression in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia. Nayera Hamdy, Clin. Lab. 2021.